These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2288154)

  • 41. Serological response to syphilis treatment. A new analysis of old data.
    Brown ST; Zaidi A; Larsen SA; Reynolds GH
    JAMA; 1985 Mar; 253(9):1296-9. PubMed ID: 3155812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A lymphotropic method of therapy for patients with fresh forms of syphilis (clinical and experimental research)].
    Zoirov PT; Khaĭdarov KKh; Isaeva MS; Iskhaki DF
    Vestn Dermatol Venerol; 1990; (12):30-4. PubMed ID: 2094098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immediate results of the comprehensive treatment of infectious forms of syphilis with erythromycin, bismuth and nonspecific preparations].
    Vasil'ev TV; Vinokuriv IN; Gracheva GK; Ivanov IA; Ovsiannikov LM
    Vestn Dermatol Venerol; 1978 Sep; (9):78-82. PubMed ID: 360681
    [No Abstract]   [Full Text] [Related]  

  • 44. [Late results of treating syphilis patients by a chronically alternating method with bicillins 1, 3 and 6 and their combinations with bismuth preparations].
    Remizov DN; Pavlovskaia VE; Rezaĭkina AV
    Vestn Dermatol Venerol; 1979 Aug; (8):64-8. PubMed ID: 494749
    [No Abstract]   [Full Text] [Related]  

  • 45. [Late results of the therapy of early forms of syphilis with penicillin preparations in combination with pyrogenic agents].
    Shinskiĭ GE; Korobeĭnikova EA; Rubtsova ZA; Nagovitsina TA
    Vestn Dermatol Venerol; 1979 Mar; (3):58-61. PubMed ID: 371239
    [No Abstract]   [Full Text] [Related]  

  • 46. Robust pro-inflammatory immune response is associated with serological cure in patients with syphilis: an observational study.
    Pastuszczak M; Gozdzialska A; Jakiela B; Obtulowicz A; Jaskiewicz J; Wojas-Pelc A
    Sex Transm Infect; 2017 Feb; 93(1):11-14. PubMed ID: 27356549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Late results of the continuous pyrogen-penicillin therapy of recurrent and early latent syphilis].
    Iarovinskiĭ BG
    Vestn Dermatol Venerol; 1979 Mar; (3):61-5. PubMed ID: 371240
    [No Abstract]   [Full Text] [Related]  

  • 48. [Azithromycin in the treatment of syphilis].
    Mashkilleĭson AL
    Antibiot Khimioter; 1994 Jun; 39(6):36-8. PubMed ID: 7848005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of serological cure and serofast state after treatment in HIV-negative patients with early syphilis in China.
    Li J; Wang LN; Zheng HY
    Sex Transm Infect; 2013 Feb; 89(1):69. PubMed ID: 22914681
    [No Abstract]   [Full Text] [Related]  

  • 50. [Jarisch-Herxheimer's reaction as a manifestation of specific antigen-antibody reactions].
    Dobrzhanskaia RS
    Vestn Dermatol Venerol; 1978 Nov; (11):77-83. PubMed ID: 366949
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical significance of the exacerbation reaction in syphilis].
    Frishman MP; Dunaeva GA
    Vestn Dermatol Venerol; 1975 Dec; (12):36-41. PubMed ID: 1229669
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of seropositive primary syphilis: an evaluation of 196 patients.
    Fiumara NJ
    Sex Transm Dis; 1977; 4(3):92-5. PubMed ID: 929349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of the continuous therapy of early forms of syphilis with penicillin preparations in combination with pyrogenic agents].
    Korobeĭnikova EA
    Vestn Dermatol Venerol; 1978 Jun; (6):84-8. PubMed ID: 354251
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of mildronate in therapy of seroresistant syphilis (serologic and immunologic comparisons].
    Glozman VN; Berenbeĭn BA; Kirmane RE; Pervushina NV; Shur AA; Agranovskiĭ VB
    Antibiot Khimioter; 1991 May; 36(5):38-9. PubMed ID: 1953172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nelson-Mayer test in treated secondary recurrent syphilis].
    Zajac W; Pucilo K; Chodynicka B
    Przegl Dermatol; 1976; (6 Suppl):483-6. PubMed ID: 1032202
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical study of ampicillin in the therapy of primary and secondary active syphilis].
    Mirakhmedov UM; Liuban BL; Mukhammed AA; Khashimov BI
    Vestn Dermatol Venerol; 1975 Nov; (11):84-7. PubMed ID: 1220386
    [No Abstract]   [Full Text] [Related]  

  • 57. [Method of treating patients suffering simultaneously from the early stage of syphilis and gonorrhea].
    Anton'ev AA; Milich MV; Astashkina YK; Batkaev EA
    Vestn Dermatol Venerol; 1978 Aug; (8):69-71. PubMed ID: 695922
    [No Abstract]   [Full Text] [Related]  

  • 58. [Quantitative method for the immunofluorescence reaction with the cerebrospinal fluid of patients with various forms of syphilis].
    Iakovleva NI
    Vestn Dermatol Venerol; 1975 Feb; (2):31-6. PubMed ID: 1098301
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immediate results of methicillin treatment of patients with contagious forms of syphilis].
    Vasil'ev TV; Dragomanov DS; Rakhnamova NV
    Vestn Dermatol Venerol; 1975 Jun; (6):80-5. PubMed ID: 1163119
    [No Abstract]   [Full Text] [Related]  

  • 60. [Criteria for the cure of syphilis].
    Ovchinnikov NM; Vasil'ev TV; Korbut SE; Sazonova LV; Vinokurov IN
    Vestn Dermatol Venerol; 1978 Aug; (8):28-32. PubMed ID: 695910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.